Neidio i'r cynnwys
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Iaith
Pob Maes
Teitl
Awdur
Pwnc
Rhif Galw
ISBN/ISSN
Tag
Canfod
Uwch
Osteoprotegerin inhibits the d...
Dyfynnu hwn
Anfonwch hwn fel neges destun
E-bostio hwn
Argraffu
Allforio Cofnod
Allforio i RefWorks
Allforio i EndNoteWeb
Allforio i EndNote
Permanent link
Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma
Show other versions (1)
Manylion Llyfryddiaeth
Prif Awduron:
Croucher, P
,
Shipman, C
,
Perry, M
,
Lippitt, J
,
Asosingh, K
,
van Beek, E
,
Van Camp, B
,
Russell, R
,
Dunstan, C
,
Vanderkerken, K
Fformat:
Journal article
Cyhoeddwyd:
2001
Daliadau
Disgrifiad
Other Versions (1)
Eitemau Tebyg
Dangos Staff
Disgrifiad
Crynodeb:
Eitemau Tebyg
Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma.
gan: Croucher, P, et al.
Cyhoeddwyd: (2001)
Osteoprotegerin (OPG) inhibits the development of osteolytic bone disease in the 5T2MM model of multiple myeloma.
gan: Croucher, P, et al.
Cyhoeddwyd: (2000)
Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease.
gan: Croucher, P, et al.
Cyhoeddwyd: (2003)
Zoledronic acid inhibits the development of osteolytic bone disease and increases disease free survival in a murine model of multiple myeloma.
gan: Croucher, P, et al.
Cyhoeddwyd: (2001)
Osteoprotegerin and the development of myeloma bone disease
gan: Croucher, P, et al.
Cyhoeddwyd: (2004)